TY - JOUR
T1 - Hypervariable Region 1 Deletion and Required Adaptive Envelope Mutations Confer Decreased Dependency on Scavenger Receptor Class B Type I and Low Density Lipoprotein Receptor for Hepatitis C Virus
AU - Prentoe, Jannick
AU - Serre, Stéphanie B N
AU - Ramirez, Santseharay
AU - Nicosia, Alfredo
AU - Gottwein, Judith M
AU - Bukh, Jens
N1 - J. Virol. February 2014 vol. 88 no. 3 1725-1739
PY - 2014
Y1 - 2014
N2 - Hypervariable region 1 (HVR1) of envelope protein 2 (E2) of hepatitis C virus (HCV) serves important, yet undefined, roles in the viral life cycle. We previously showed that viability of HVR1-deleted JFH1-based recombinants with Core-NS2 of H77 (H77ΔHVR1, genotype 1a) and S52 (S52ΔHVR1, 3a) in Huh7.5 cells was rescued by E2 substitutions N476D/S733F and E1 substitution A369V, respectively; HVR1-deleted J6 (J6ΔHVR1, 2a) was fully viable. In single-cycle production assays, where HCV RNA was transfected into entry-deficient Huh7-derived S29 cells with low CD81 expression, we found no effect of HVR1 deletion on replication or particle release for H77 and S52. HCV pseudo-particle assays in Huh7.5 cells showed that HVR1 deletion decreased entry by 20-100 fold for H77, J6, and S52; N476D/S733F restored entry for H77ΔHVR1, but A369V further decreased S52ΔHVR1 entry. We investigated receptor usage by antibody blocking and receptor silencing in Huh7.5 cells, followed by inoculation of parental and HVR1-deleted HCV recombinants. Compared to parental viruses, scavenger receptor class B type I (SR-BI) dependency was decreased for H77ΔHVR1/N476D/S733F, H77N476D/S733F, S52ΔHVR1/A369V, and S52A369V, but not for J6ΔHVR1. Low-density lipoprotein receptor (LDLr) dependency was decreased for HVR1-deleted viruses, but not for H77N476D/S733F and S52A369V. Soluble LDLr neutralization revealed strong inhibition of parental HCV, but limited effect against HVR1-deleted viruses. Apolipoprotein E (ApoE)-specific HCV neutralization was similar for H77, J6, and S52 viruses with and without HVR1. In conclusion, HVR1 and HVR1-related adaptive envelope mutations appeared involved in LDLr and SR-BI dependency, respectively. Also, LDLr served ApoE-independent, but HVR1-dependent functions in HCV entry.
AB - Hypervariable region 1 (HVR1) of envelope protein 2 (E2) of hepatitis C virus (HCV) serves important, yet undefined, roles in the viral life cycle. We previously showed that viability of HVR1-deleted JFH1-based recombinants with Core-NS2 of H77 (H77ΔHVR1, genotype 1a) and S52 (S52ΔHVR1, 3a) in Huh7.5 cells was rescued by E2 substitutions N476D/S733F and E1 substitution A369V, respectively; HVR1-deleted J6 (J6ΔHVR1, 2a) was fully viable. In single-cycle production assays, where HCV RNA was transfected into entry-deficient Huh7-derived S29 cells with low CD81 expression, we found no effect of HVR1 deletion on replication or particle release for H77 and S52. HCV pseudo-particle assays in Huh7.5 cells showed that HVR1 deletion decreased entry by 20-100 fold for H77, J6, and S52; N476D/S733F restored entry for H77ΔHVR1, but A369V further decreased S52ΔHVR1 entry. We investigated receptor usage by antibody blocking and receptor silencing in Huh7.5 cells, followed by inoculation of parental and HVR1-deleted HCV recombinants. Compared to parental viruses, scavenger receptor class B type I (SR-BI) dependency was decreased for H77ΔHVR1/N476D/S733F, H77N476D/S733F, S52ΔHVR1/A369V, and S52A369V, but not for J6ΔHVR1. Low-density lipoprotein receptor (LDLr) dependency was decreased for HVR1-deleted viruses, but not for H77N476D/S733F and S52A369V. Soluble LDLr neutralization revealed strong inhibition of parental HCV, but limited effect against HVR1-deleted viruses. Apolipoprotein E (ApoE)-specific HCV neutralization was similar for H77, J6, and S52 viruses with and without HVR1. In conclusion, HVR1 and HVR1-related adaptive envelope mutations appeared involved in LDLr and SR-BI dependency, respectively. Also, LDLr served ApoE-independent, but HVR1-dependent functions in HCV entry.
U2 - 10.1128/JVI.02017-13
DO - 10.1128/JVI.02017-13
M3 - Journal article
C2 - 24257605
SN - 0022-538X
VL - 88
SP - 1725
EP - 1739
JO - Journal of Virology
JF - Journal of Virology
IS - 3
ER -